安旭生物股东马华祥拟减持不超0.94%股份

Core Viewpoint - Anxu Bio (688075.SH) announced that shareholder Ma Huaxiang plans to reduce his holdings by up to 1.2 million shares, representing no more than 0.94% of the company's total share capital due to personal funding needs [1] Summary by Relevant Categories - Shareholder Actions - Shareholder Ma Huaxiang intends to reduce his stake in the company through centralized bidding transactions [1] - The total number of shares to be reduced is capped at 1.2 million [1] - Impact on Company - The reduction represents a maximum of 0.94% of the company's total share capital [1]